KLI

Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response

Metadata Downloads
Publisher
CANCER RESEARCH AND TREATMENT
Language
영어
ISSN
1598-2998
Citation Volume
52
Citation Number
2
Citation Start Page
594
Citation End Page
603
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.